Johanna M. Niers

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Self-reported physical functioning and physical fitness in glioma patients.

Self-reported physical functioning and physical fitness in glioma patients.

Journal: Neuro-oncology practice
Published: March 09, 2026

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Journal: The Lancet. Haematology
Published: January 08, 2026

Promoting physical activity in glioma patients: Insights from Dutch healthcare professionals.

Promoting physical activity in glioma patients: Insights from Dutch healthcare professionals.

Journal: Neuro-oncology practice
Published: October 03, 2025

Cannabis use among Dutch patients with a primary brain tumor.

Cannabis use among Dutch patients with a primary brain tumor.

Journal: Neuro-oncology practice
Published: August 15, 2025

Bayesian adaptive randomized trial of blended cognitive behavioral therapy for severe fatigue in stable diffuse glioma.

Bayesian adaptive randomized trial of blended cognitive behavioral therapy for severe fatigue in stable diffuse glioma.

Journal: Neuro-oncology
Published: July 21, 2025

Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.

Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.

Journal: Neuro-oncology
Published: July 21, 2025

Impact of resection location on depressive symptoms following glioma surgery.

Impact of resection location on depressive symptoms following glioma surgery.

Journal: Neuro-oncology advances
Published: May 16, 2025

Baseline factors relating to depressive symptoms at one year postoperative in patients with diffuse glioma.

Baseline factors relating to depressive symptoms at one year postoperative in patients with diffuse glioma.

Journal: Neuro-oncology practice
Published: February 07, 2025

[18F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.

[18F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.

Journal: Trials
Published: November 11, 2024

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Journal: Nature cancer
Published: February 28, 2024

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Journal: Neuro-oncology advances
Published: November 29, 2023

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.

Journal: Cancer research
Published: July 14, 2023
Showing 1-12 of 17

Last Updated: 09/26/2026